Blog
The United States Patent and Trademark Office (USPTO) released a report on Monday that paints a rather dire picture for women inventors. The report, “Progress and Potential: A profile of women inventors on U.S.
The Trump administration yesterday made some firm statements about reducing health care and drug prices for American consumers and making costs more transparent.
The Trump administration yesterday made some firm statements about reducing health care and drug prices for American consumers and making costs more transparent.
The government of Malaysia continues to face pressure from the United States pharmaceutical industry and potentially the US government to undo an action taken to make a key hepatitis C medicine more affordable in the country.
The government of Malaysia continues to face pressure from the United States pharmaceutical industry and potentially the US government to undo an action taken to make a key hepatitis C medicine more affordable in the country.
On the morning of February 14, the New Hampshire Supreme Court will hear what could be one of this year’s most important set of arguments related to patent ownership taking place outside of the federal judiciary.
Only two things worked out well for Qualcomm on the litigation front this year: the Lasinski cross-examination and the fact that
By Donald Zuhn –- Last week, in Athena Diagnostics, Inc. v. Mayo Collaborative Services, LLC, the Federal Circuit affirmed the decision by the District Court for the District of Massachusetts, holding claims 6-9 of U.S. Patent No.
Here we go again! Another patent whose claims have been invalidated at the Federal Circuit—predictably, another medical diagnostic patent. Athena Diagnostics v. Mayo Collaborative (Fed. Cir. Feb. 6, 2019).
The Federal Circuit on February 1 affirmed the Patent Trial and Appeal Board’s final written decision in an inter partes review concluding that the claims of a patent directed to a composition for treating epilepsy are not unpatentable.